ATE479771T1 - Menschliche hodenspezifische serin/threonin- kinase - Google Patents

Menschliche hodenspezifische serin/threonin- kinase

Info

Publication number
ATE479771T1
ATE479771T1 AT01986508T AT01986508T ATE479771T1 AT E479771 T1 ATE479771 T1 AT E479771T1 AT 01986508 T AT01986508 T AT 01986508T AT 01986508 T AT01986508 T AT 01986508T AT E479771 T1 ATE479771 T1 AT E479771T1
Authority
AT
Austria
Prior art keywords
kinases
threonine kinase
human testis
specific serine
family
Prior art date
Application number
AT01986508T
Other languages
German (de)
English (en)
Inventor
John Herr
Pablo Visconti
Zhonglin Hao
Original Assignee
Univ Virginia
Kopf Gregory S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia, Kopf Gregory S filed Critical Univ Virginia
Application granted granted Critical
Publication of ATE479771T1 publication Critical patent/ATE479771T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01986508T 2000-11-09 2001-11-09 Menschliche hodenspezifische serin/threonin- kinase ATE479771T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24693900P 2000-11-09 2000-11-09
US26492101P 2001-01-30 2001-01-30
PCT/US2001/046803 WO2002038732A2 (en) 2000-11-09 2001-11-09 Human testis specific serine/threonine kinase

Publications (1)

Publication Number Publication Date
ATE479771T1 true ATE479771T1 (de) 2010-09-15

Family

ID=26938336

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01986508T ATE479771T1 (de) 2000-11-09 2001-11-09 Menschliche hodenspezifische serin/threonin- kinase
AT03018045T ATE477332T1 (de) 2000-11-09 2001-11-09 Menschliche hodenspezifische serin/threonin- kinase

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03018045T ATE477332T1 (de) 2000-11-09 2001-11-09 Menschliche hodenspezifische serin/threonin- kinase

Country Status (8)

Country Link
US (2) US7129057B2 (enExample)
EP (1) EP1339866B1 (enExample)
JP (5) JP2004513631A (enExample)
AT (2) ATE479771T1 (enExample)
AU (4) AU3769902A (enExample)
DE (2) DE60142804D1 (enExample)
IL (4) IL155801A0 (enExample)
WO (1) WO2002038732A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030108933A1 (en) * 2000-05-12 2003-06-12 Burkhard Scharm Novel serine-threonine kinase-3
US20050032146A1 (en) * 2003-08-07 2005-02-10 Herr John C. Tssk4: a human testis specific serine/threonine kinase
JP2008515797A (ja) * 2004-09-30 2008-05-15 ユニバーシティ オブ バージニア パテント ファウンデーション オスの避妊標的物としてのｔｓｓｋファミリーメンバーおよびｔｓｋｓの評価
JP2008067649A (ja) * 2006-09-14 2008-03-27 Osaka Univ 妊孕性診断キット、変異検出方法、ポリヌクレオチド、及びポリペプチド
CN115976033B (zh) * 2022-12-14 2024-05-17 西南大学 瓜实蝇tssk1和tssk3基因及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5173400A (en) * 1999-05-28 2000-12-18 Sugen, Inc. Protein kinases
AU2292301A (en) * 1999-12-23 2001-07-03 Incyte Genomics, Inc. Human kinases
US20040048249A1 (en) * 2000-01-21 2004-03-11 Tang Y. Tom Novel nucleic acids and secreted polypeptides
AU2001234944A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1278866A2 (en) * 2000-05-05 2003-01-29 MERCK PATENT GmbH Serine-threonine kinase
US6482935B1 (en) * 2000-05-24 2002-11-19 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002068649A2 (en) * 2001-01-31 2002-09-06 Curagen Corporation Proteins and nucleic acids encoding same
US20030211093A1 (en) * 2001-07-20 2003-11-13 Henry Yue Human kinases

Also Published As

Publication number Publication date
JP2004135653A (ja) 2004-05-13
AU3769902A (en) 2002-05-21
JP2004513631A (ja) 2004-05-13
US20030211563A1 (en) 2003-11-13
JP2010029197A (ja) 2010-02-12
EP1339866A4 (en) 2006-10-25
US20040030112A1 (en) 2004-02-12
IL155801A (en) 2009-12-24
AU2006202059A2 (en) 2006-06-15
JP2007306930A (ja) 2007-11-29
DE60142804D1 (de) 2010-09-23
DE60142984D1 (de) 2010-10-14
US6946275B2 (en) 2005-09-20
AU2002237699B2 (en) 2006-05-25
EP1339866A2 (en) 2003-09-03
AU2002237699B9 (en) 2006-06-29
IL155801A0 (en) 2003-12-23
IL155800A (en) 2009-09-01
JP2009148281A (ja) 2009-07-09
WO2002038732A3 (en) 2002-12-05
ATE477332T1 (de) 2010-08-15
IL155800A0 (en) 2003-12-23
WO2002038732A2 (en) 2002-05-16
AU2006202059B2 (en) 2009-01-08
AU2006202059C1 (en) 2009-06-11
AU2006202059A1 (en) 2006-06-15
EP1339866B1 (en) 2010-09-01
US7129057B2 (en) 2006-10-31
AU2003204266B2 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
NO20053144L (no) Chk-, Pdk- og Akt-inhibitorpyrimidiner, deres fremstilling og anvendelse som famasoytiske midler.
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
DE60234778D1 (de) Verwendung von il-18-hemmern zur behandlung oder prävention von sepsis
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
WO2000043373A3 (en) Kinase inhibitors
DK1648905T3 (da) Inhibitorer for thienopyridin- og furopyridinkinase
WO2003031606A3 (en) Crystal structure of an aurora kinase catalytic domain, and use thereof
DK0970095T3 (da) Hidtil ukendte benzimidazolinhibitorer for fructose-1,6-bisphosphase
ATE400274T1 (de) Hemmstoffe der akt aktivität
SV2003001173A (es) 1-alquil o 1-cicloalquil-triazolo [4,3-a] quinazolin-5- onas como inhibidoras de fosfodiesterasa
DE60039059D1 (de) Triazin-kinase-hemmer
WO2004009597A3 (en) Pyrazolopyrimidines as protein kinase inhibitors
EP1737843A4 (en) HEMMER OF ACT ACTIVITY
YU84603A (sh) Novi inhibitori tirozin kinaze
EP1620411A4 (en) HEMMER OF ACT ACTIVITY
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
WO2004030620A3 (en) Novel tyrosine kinase inhibitors
BG106867A (en) Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory autoimmune and respiratory diseases
ATE477332T1 (de) Menschliche hodenspezifische serin/threonin- kinase
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
EP1448582A4 (en) TELOMERASE INTERFERENCE
EP1443117A3 (en) Human testis specific serine/threonine kinase
WO2005023186A3 (en) Methods of identifying agents that inhibit the growth of cancer cells
EP1201764A3 (en) Assays for identifying phosphatase inhibitors
SE0302965D0 (sv) Hämmare av DNA-Metyltransferasisoformer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties